title: A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.
abstract: Huntington disease (HD) is an inherited neurodegenerative disease caused by a CAG expansion in the HTT gene. Using yeast two-hybrid methods, we identified a large set of proteins that interact with huntingtin (HTT)-interacting proteins. This network, composed of HTT-interacting proteins (HIPs) and proteins interacting with these primary nodes, contains 3235 interactions among 2141 highly interconnected proteins. Analysis of functional annotations of these proteins indicates that primary and secondary HIPs are enriched in pathways implicated in HD, including mammalian target of rapamycin, Rho GTPase signaling, and oxidative stress response. To validate roles for HIPs in mutant HTT toxicity, we show that the Rho GTPase signaling components, BAIAP2, EZR, PIK3R1, PAK2, and RAC1, are modifiers of mutant HTT toxicity. We also demonstrate that Htt co-localizes with BAIAP2 in filopodia and that mutant HTT interferes with filopodial dynamics. These data indicate that HTT is involved directly in membrane dynamics, cell attachment, and motility. Furthermore, they implicate dysregulation in these pathways as pathological mechanisms in HD.
authors.affiliation: Buck Institute for Research on Aging, Novato, California 94945.
authors.forename: Cendrine
authors.initials: C
authors.lastname: Tourette
authors.affiliation: Buck Institute for Research on Aging, Novato, California 94945.
authors.forename: Biao
authors.initials: B
authors.lastname: Li
authors.affiliation: Prolexys Pharmaceuticals, Salt Lake City, Utah 84116; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112.
authors.forename: Russell
authors.initials: R
authors.lastname: Bell
authors.affiliation: Buck Institute for Research on Aging, Novato, California 94945.
authors.forename: Shannon
authors.initials: S
authors.lastname: O'Hare
authors.affiliation: Prolexys Pharmaceuticals, Salt Lake City, Utah 84116; Center for Drug Discovery and Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27704.
authors.forename: Linda S
authors.initials: LS
authors.lastname: Kaltenbach
authors.affiliation: Buck Institute for Research on Aging, Novato, California 94945. Electronic address: smooney@buckinstitute.org.
authors.forename: Sean D
authors.initials: SD
authors.lastname: Mooney
authors.affiliation: Buck Institute for Research on Aging, Novato, California 94945. Electronic address: rhughes@buckinstitute.org.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Hughes
mesh_terms: D000818:Animals; D057809:HEK293 Cells; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics / Q000378:metabolism*; D053858:Metabolic Networks and Pathways; D051379:Mice; D041681:NIH 3T3 Cells; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D011554:Pseudopodia / Q000378:metabolism; D020741:rho GTP-Binding Proteins / Q000378:metabolism*
chemical_list: C119539:BAIAP2 protein, human; C086055:HTT protein, human; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D020741:rho GTP-Binding Proteins
keywords: Cell Death; Cell Motility; Computational Biology; Huntington Disease; Neurodegeneration; Neurodegenerative Diseases; Protein-Protein Interactions; Proteomics; Rho GTPases